Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis

Vaccine

Volumn 33, Issue 15, 2015, Pages 1808-1814

  Arnold, Isabelle C ^a   Hutchings, Claire ^b   Kondova, Ivanela ^c   Hey, Ariann ^b   Powrie, Fiona ^a   Beverley, Peter ^b   Tchilian, Elma ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Interleukin 10; Microbiota; Subunit vaccine; Tuberculosis

Indexed keywords

ADENOVIRUS VACCINE; IMMUNODOMINANT ANTIGEN 85A; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; MESSENGER RNA; MYCOBACTERIUM ANTIGEN; RECOMBINANT VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BCG VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL LOAD; CONTROLLED STUDY; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; HUMAN ADENOVIRUS 5; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION SENSITIVITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS; ANIMAL; BAGG ALBINO MOUSE; COLON; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN ADENOVIRUS C; IMMUNOLOGY; INTESTINE FLORA; INTRANASAL DRUG ADMINISTRATION; LUNG; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

ADENOVIRUSES, HUMAN; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL LOAD; COLON; GASTROINTESTINAL MICROBIOME; HELICOBACTER HEPATICUS; HELICOBACTER INFECTIONS; HUMANS; INTERLEUKIN-10; LUNG; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 84925295903     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.02.041     Document Type: Article

References (30)

1. Lienhardt C., Glaziou P., Uplekar M., Lonnroth K., Getahun H., Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol 2012, 10:407-416.
2. Fine P.E. BCG: the challenge continues. Scand J Infect Dis 2001, 33:243-245.
3. Brandt L., Feino Cunha J., Weinreich Olsen A., Chilima B., Hirsch P., Appelberg R., et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002, 70:672-678.
4. Beverley P., Ronan E., Lee L., Arnold I., Bolinger B., Powrie F., et al. Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A. Vaccine 2013, 31:1086-1093.
5. Potian J.A., Rafi W., Bhatt K., McBride A., Gause W., Salgame P. Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. J Exp Med 2011, 208:1863-1874.
6. Elias D., Britton S., Aseffa A., Engers H., Akuffo H. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine 2008, 26:3897-3902.
7. Perry S., de Jong B., Solnick J., de la Luz Sanchez M., Yang S., Lin Pl, et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS ONE 2010, 5. 10.1371/journal.pone.
8. Arnold I.C., Dehzad N., Reuter S., Martin H., Becher B., Taube C., et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011, 121:3088-3093.
9. Hayashimoto N., Morita H., Ishida T., Yasuda M., Kameda S., Uchida R., et al. Current microbiological status of laboratory mice and rats in experimental facilities in Japan. Exp Anim 2013, 62:41-48.
10. Kullberg M.C., Ward J., Gorelick P., Caspar P., Hieny S., Cheever A., et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998, 66:5157-5166.
11. Morrison P.J., Bending D., Fouser L.A., Wright J.F., Stockinger B., Cooke A., et al. Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation. Mucosal Immunol 2013, 6:1143-1156.
12. Song-Zhao G.X., Maloy K.J. Experimental mouse models of T cell-dependent inflammatory bowel disease. Methods Mol Biol 2014, 1193:199-211.
13. Ronan E.O., Lee L.N., Beverley P.C., Tchilian E.Z. Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection. PLoS ONE 2009, 4. 10.1371/journal.pone.0008235.
14. Maloy K.J., Salaun L., Cahill R., Dougan G., Saunders N., Powrie F. CD4+ CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003, 197:111-119.
15. Forbes E.K., Sander C., Ronan E.O., McShane H., Hill A.V., Beverley P.C.L., et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol chellenge in mice. J Immunol 2008, 181:4955-4964.
16. Kullberg M.C., Jankovic D., Gorelick P.L., Caspar P., Letterio J., Cheever A., et al. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 2002, 196:505-515.
17. Redford P.S., Murray P., O'Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol 2011, 4:261-270.
18. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346:1339-1345.
19. Brennan M.J., Thole J. Tuberculosis vaccines: a strategic blueprint for the next decade. Tuberculosis (Edinb) 2012, 92(Suppl. 1):S6-S13.
20. Chung H., Pamp S., Hill J., Surana N., Edelman S., Troy E., et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012, 149:1578-1593.
21. Olszak T., An D., Zeissig S., Vera M., Richter J., Franke A., et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336:489-493.
22. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010, 107:12204-12209.
23. Ivanov I., Frutos Rde L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
24. Ivanov I., Littman D.R. Segmented filamentous bacteria take the stage. Mucosal Immunol 2010, 3:209-212.
25. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-377.
26. Engler D.B., Reuter S., van Wijck Y., Urban S., Kyburz A., Maxeiner J., et al. Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. Proc Natl Acad Sci USA 2014, 111:11810-11815.
27. Kuehl C.J., Wood H., Marsh Tl., Schmidt T., Young V.B. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun 2005, 73:6952-6961.
28. Oh J.Z., Ravindran R., Chassaing B., Carvalho F.A., Maddur M.S., Bower M., et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 2014, 41:478-492.
29. Smaill F., Jeyanathan M., Smieja M., Medina M., Thanthrige-Don N., Zganiacz A.F., et al. A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity. Sci Transl Med 2013, 5. 10.1126/scitranslmed.3006843.
30. Beverley P.C.L., Sridhar S., Lalvani A., Tchilian E.Z. Harnessing local and systemic immunity for vaccines against tuberculosis. Mucosal Immunol 2014, 7:20-26.